Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the drug.

Biofidelity, a leader in innovative genomic solutions, today announced the launch of Aspyre Clinical Test for Lung for liquid biopsy samples. Aspyre Clinical Test for Lung analyzes all ...

Revuforj® (revumenib) is a menin inhibitor and blocks the interaction of both wild-type KMT2A and KMT2A fusion proteins with menin. The binding of KMT2A fusion proteins with menin is involved in KMT2A ...

Eventually, it was discovered that the aberrant chromosome was caused by the BCR-ABL gene fusion causing scientists to ...

The agreement will give Kuro enough capital to support the development and launch of its menin inhibitor ziftomenib.

Tagomics announces a multiomic profiling co-marketing agreement with Agilent Technologies: Cambridge, UK Thursday, November 21, 2024, 14:00 Hrs [IST] Tagomics Ltd., a pioneering b ...

Billboard counts down the best country acts of the past (almost) 100 years. Ever since Ralph Peer held his famous recording ...

There are approx. 80+ key companies which are developing the therapies for Dementia Associated With Alzheimer's Disease. The companies which have their Dementia Associated With Alzheimer's Disease ...

LY-3209590: Eli Lilly and Company Insulin efsitora alfa (LY3209590) is a once-weekly basal insulin, a fusion protein that combines a novel single-chain variant of insulin with a human IgG2 Fc domain.

Depression is one of the most common mental illnesses. As many as 280 million people worldwide are affected by this disease, which is why researchers at Kaunas University of Technology (KTU) have ...

The Philadelphia region has some of the most gorgeous homes in the country---and these agents are at the top of their game in selling them. From showcasing open-air houses down the shore to luxe ...